(3-chloro-2-fluorophenyl)-[4-[[6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyridinyl]methyl]piperazin-1-yl]methanone
C21H22ClFN6O — CID 11532031
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3-chloro-2-fluorophenyl)-[4-[[6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyridinyl]methyl]piperazin-1-yl]methanone
(3-chloro-2-fluorophenyl)-[4-[[6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyridinyl]methyl]piperazin-1-yl]methanone (PubChem CID 11532031) has the molecular formula C21H22ClFN6O and a molecular weight of 428.90 g/mol. Its IUPAC name is (3-chloro-2-fluorophenyl)-[4-[[6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyridinyl]methyl]piperazin-1-yl]methanone.
Molecular Properties
| Compound Name | (3-chloro-2-fluorophenyl)-[4-[[6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyridinyl]methyl]piperazin-1-yl]methanone |
|---|---|
| PubChem CID | 11532031 |
| Molecular Formula | C21H22ClFN6O |
| Molecular Weight | 428.90 g/mol |
| Exact Mass | 428.15 |
| IUPAC Name | (3-chloro-2-fluorophenyl)-[4-[[6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyridinyl]methyl]piperazin-1-yl]methanone |
| SMILES | Cc1cc(Nc2cccc(CN3CCN(C(=O)c4cccc(Cl)c4F)CC3)n2)n[nH]1 |
| InChI | InChI=1S/C21H22ClFN6O/c1-14-12-19(27-26-14)25-18-7-2-4-15(24-18)13-28-8-10-29(11-9-28)21(30)16-5-3-6-17(22)20(16)23/h2-7,12H,8-11,13H2,1H3,(H2,24,25,26,27) |
| InChIKey | OLDJGLDAEVUBMQ-UHFFFAOYSA-N |
| XLogP | 3.61 |
| TPSA | 77.15 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 428.90 |
| LogP ≤ 5 | 3.61 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 11532031 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.